Cargando…
Serum Clusterin and Complement Factor H May Be Biomarkers Differentiate Primary Sjögren's Syndrome With and Without Neuromyelitis Optica Spectrum Disorder
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a neurological complication of primary Sjögren's syndrome (pSS). Objective: We aimed to explore potential serological differences between pSS patients with and without NMOSD. Methods: There were 4 pSS patients with NMOSD and 8 pSS pa...
Autores principales: | Qiao, Lin, Deng, Chuiwen, Wang, Qian, Zhang, Wen, Fei, Yunyun, Xu, Yan, Zhao, Yan, Li, Yongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823228/ https://www.ncbi.nlm.nih.gov/pubmed/31708932 http://dx.doi.org/10.3389/fimmu.2019.02527 |
Ejemplares similares
-
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article
por: Qiao, Lin, et al.
Publicado: (2015) -
Higher frequency of brain abnormalities in neuromyelitis optica spectrum disorder patients without primary Sjögren's syndrome
por: Gu, Li-na, et al.
Publicado: (2016) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
A Rare Case of Neuromyelitis Optica Spectrum Disorder in Patient with Sjogren's Syndrome
por: Thongpooswan, Supat, et al.
Publicado: (2014) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)